Carlsbad’s Obalon Therapeutics has filed to raise up to &75 million in an initial public offering, according to a regulatory filing made Friday.
Obalon is preparing to sell an intragastric balloon to help with weight loss. By displacing food that would otherwise be eaten, the balloon is expected to cause patients to eat less. Proceeds from the offering will help with its commercialization.
